Market Tracker

05/18 5:15pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

56.77
Delayed Data
As of May 18
 -0.56 / -0.98%
Today’s Change
45.31
Today|||52-Week Range
68.59
+6.11%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close57.33
Today’s open57.33
Day’s range56.47 - 57.61
Volume633,325
Average volume (3 months)1,109,456
Market cap$9.1B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-105.23%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+15.33%
P/E ratioNM
Price/Sales15.88
Price/Book12.27

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.26+0.57%
ALNYAlnylam Pharmaceutic...+1.17+1.15%
TSROTESARO Inc-2.87-5.67%
IONSIonis Pharmaceutical...+0.81+1.85%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$482.3M
Annual profit (last year)-$125.5M
Net profit margin-26.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
CFO &
Principal Accounting Officer
Todd E. Simpson
Corporate headquarters
Bothell, Washington

Forecasts